Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ravi Anand, MD
Newron Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- South Metropolitan Health Service Fiona Stanley Hospital
Murdoch, Western Australia, Australia
- Amrita Institute of Medical Sciences
Kochi, Kerala, India
- Vijaya Health Centre
Chennai, Tamil Nadu, India
- Jaslok Hospital and Research Centre
Mumbai, India
- P.D. Hinduja National Hospital and Medical Research Centre
Mumbai, India
- All India Institute of Medical Sciences
New Delhi, India
- A.O.U. Senese Policlinico Santa Maria Alle Scotte
Siena, Tuscany, Italy
- U.O. Neuropsichiatria Infantile
Milan, Italy
- King'S College Hospital
London, United Kingdom
- University of Alabama
Birmingham, Alabama, United States
- University of California
San Diego, California, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Gillette Children'S Specialty Healthcare
Saint Paul, Minnesota, United States
- Baylor College of Medicine
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Oct 2016
- Primary completion
- 6 Aug 2019
- Completion
- 4 May 2020
- Last update posted
- 21 Dec 2021
- Registered enrollment
- 129
- Registry id
- NCT02790034
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.